BC
Broadfin Capital Portfolio holdings
AUM
$403M
This Quarter Return
+27.34%
1 Year Return
+74.97%
3 Year Return
+245.63%
5 Year Return
+336.04%
10 Year Return
–
AUM
$563M
AUM Growth
+$563M
(+10%)
Cap. Flow
-$79.5M
Cap. Flow
% of AUM
-14.11%
Top 10 Holdings %
Top 10 Hldgs %
49.74%
Holding
64
New
14
Increased
14
Reduced
19
Closed
7
Top Buys
| 1 |
ACGN
Aceragen, Inc. Common Stock
ACGN
|
$7.87M |
| 2 |
NUVA
NuVasive, Inc.
NUVA
|
$7.35M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$6.3M |
| 4 |
TherapeuticsMD
TXMD
|
$6.24M |
| 5 |
SPNC
Spectranetics Corp
SPNC
|
$6M |
Top Sells
| 1 |
NPSP
NPS PHARMACEUTICALS INC
NPSP
|
$39.6M |
| 2 |
ANTH
Anthera Pharmaceuticals, Inc.
ANTH
|
$14M |
| 3 |
Integra LifeSciences
IART
|
$11.3M |
| 4 |
LCI
Lannett Company, Inc.
LCI
|
$11.2M |
| 5 |
IPXL
Impax Laboratories, Inc.
IPXL
|
$9.74M |
Sector Composition
| 1 | Healthcare | 77.84% |
